Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
The following section summarizes insights on Yield10 Bioscience Inc's Gross Profit Cumulative Growth (5y):
We've identified the following companies as similar to Yield10 Bioscience Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Gross Profit Cumulative Growth (5y) |
|---|---|---|
| 4D Molecular Therapeutics Inc | NASDAQGS:FDMT | -345.2% |
| Ionis Pharmaceuticals Inc | NASDAQGS:IONS | -131.7% |
| Keros Therapeutics Inc | NASDAQGM:KROS | -99.8% |
| Yield10 Bioscience Inc | OTCPK:YTEN.Q | -95.5% |
| Organovo Holdings Inc | NASDAQCM:ONVO | 55.6% |
| Healthcare | SECTOR:HLTH.US | 60.6% |
| Biomarin Pharmaceutical Inc | NASDAQGS:BMRN | 261.1% |
| Ardelyx Inc | NASDAQGM:ARDX | 444.4% |
| Apollomics Inc | NASDAQCM:APLM | NA |
| OncoCyte Corp | NASDAQCM:OCX | NA |
| Clene Inc. | NASDAQCM:CLNN | NA |
| Molecular Templates Inc | OTCPK:MTEM | 149.8% |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Gross Profit Cumulative Growth (5y) in the growth category include:
Cumulative gross profit growth over the last five years
The chart above depicts the distribution of Gross Profit Cumulative Growth (5y) for companies operating in the Healthcare Sector in the Developed economic region. Over 1,500 companies were considered in this analysis, and 1,442 had meaningful values. The average Gross Profit Cumulative Growth (5y) of companies in the Sector is 183.8% with a standard deviation of 563.7%. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Yield10 Bioscience Inc's Gross Profit Cumulative Growth (5y) of -95.5% ranks in the 6.5% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,502 |
| Included Constituents | 1,442 |
| Min | -464.4% |
| Max | 4,998.1% |
| Median | 49.7% |
| Mean | 183.8% |
| Standard Deviation | 563.7% |
You can find companies with similar Gross Profit Cumulative Growth (5y) using this stock screener.